HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James P Edwards Selected Research

1- (3- (4- (6- Chloro- 2,3- dihydro- 3- methyl- 2- oxo- 1H- benzimidazol- 1- yl)- 1- piperidinyl)propyl)- 4,5,6,7- tetrahydro- 5- (methylsulfonyl)- 3- (4- (trifluoromethyl)phenyl)- 1H- pyrazolo(4,3- c)pyridine

1/2004Identification of a potent and selective noncovalent cathepsin S inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James P Edwards Research Topics

Disease

3Inflammation (Inflammations)
01/2020 - 04/2004
2Neoplasms (Cancer)
12/2021 - 09/2017
2Rheumatoid Arthritis
01/2020 - 01/2017
2Psoriasis (Pustulosis Palmaris et Plantaris)
01/2018 - 01/2017
2Agranulocytosis (Granulocytopenia)
01/2017 - 03/2014
2Asthma (Bronchial Asthma)
01/2017 - 03/2014
2Atopic Dermatitis (Atopic Eczema)
01/2017 - 03/2014
2Peritonitis
06/2007 - 04/2004
1Adenoma (Adenomas)
12/2021
1Colorectal Neoplasms (Colorectal Cancer)
12/2021
1Hyperalgesia
08/2020
1Neuralgia (Stump Neuralgia)
08/2020
1Peripheral Nerve Injuries
08/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020
1Pruritus (Itching)
01/2017
1Melanoma (Melanoma, Malignant)
03/2008
1Otitis
06/2007
1Edema (Dropsy)
06/2007
1Atherosclerosis
05/2005
1Arthritis (Polyarthritis)
05/2005
1Chronic Obstructive Pulmonary Disease (COPD)
05/2005
1Hypersensitivity (Allergy)
01/2004
1Autoimmune Diseases (Autoimmune Disease)
01/2004

Drug/Important Bio-Agent (IBA)

2CytokinesIBA
08/2020 - 01/2020
2cathepsin SIBA
08/2020 - 05/2005
21- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA
01/2017 - 04/2004
24- (3- aminopyrrolidin- 1- yl)- 6- isopropylpyrimidin- 2- ylamineIBA
01/2017 - 03/2014
2Pharmaceutical PreparationsIBA
01/2017 - 03/2014
2ZymosanIBA
06/2007 - 04/2004
1Celecoxib (Celebrex)FDA Link
12/2021
1Phosphotransferases (Kinase)IBA
12/2021
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
12/2021
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2021
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2021
1Analgesics (Analgesic Drugs)IBA
08/2020
1Immunoglobulin G (IgG)IBA
01/2020
1Janus Kinase InhibitorsIBA
01/2020
1CollagenIBA
01/2020
1AcidsIBA
01/2018
1Immune Checkpoint ProteinsIBA
09/2017
1Biological ProductsIBA
09/2017
1toreforantIBA
01/2017
1Histamine (Histamine Dihydrochloride)FDA Link
03/2014
1Mitogen-Activated Protein Kinase 3IBA
03/2008
1Biomarkers (Surrogate Marker)IBA
03/2008
1Interleukin-8 (Interleukin 8)IBA
03/2008
1AgarIBA
03/2008
1cysteinyl-leukotrieneIBA
06/2007
1Arachidonic Acid (Vitamin F)IBA
06/2007
11- (4- (benzothiazol- 2- yloxy)benzyl)piperidine- 4- carboxylic acidIBA
06/2007
1Carboxylic AcidsIBA
06/2007
1LipoxinsIBA
06/2007
1zileuton (Zyflo)FDA Link
06/2007
1piperidineIBA
06/2007
11- (3- (4- (6- Chloro- 2,3- dihydro- 3- methyl- 2- oxo- 1H- benzimidazol- 1- yl)- 1- piperidinyl)propyl)- 4,5,6,7- tetrahydro- 5- (methylsulfonyl)- 3- (4- (trifluoromethyl)phenyl)- 1H- pyrazolo(4,3- c)pyridineIBA
01/2004

Therapy/Procedure

1Chemoprevention
12/2021
1Immunotherapy
09/2017